Table 4.
Comparison of clinical and laboratory parameters between confirmed cases (primary aldosteronism) and control groups.
| Groups | p | ||
|---|---|---|---|
| Control | Case | ||
| Male, number/total (%) |
40.5% | 40.9% | 0.885a |
| Age (years old) | |||
| N, Mean ± SD | 59.2 ± 13.1 | 54.8 ± 12 | <0.001 |
| BMI (kg/m2) | |||
| N, Mean ± SD | 29.68 ± 5.65 | 29.31 ± 4.83 | 0.426 |
| SBP (mmHg) | |||
| N, Mean ± SD | 160.43 ± 30.6 | 147.7 ± 31.73 | <0.001 |
| DBP (mmHg) | |||
| N, Mean ± SD | 96.12 ± 17.94 | 90.52 ± 17.19 | <0.001 |
| Creatinine (mg/dL) | |||
| N, Mean ± SD | 1.29 ± 1.18 | 1.10 ± 0.54 | 0.021 |
| K+ (mEq/L) | |||
| N, Mean ± SD | 4.29 ± 0.52 | 3.72 ± 0.84 | <0.001 |
| Urinary Na+ (mEq/L) | |||
| N, Mean ± SD | 174.2 ± 82.25 | 160.05 ± 73.11 | 0.301 |
| HbA1c (%) | |||
| N, Mean ± SD | 6.51 ± 1.53 | 6.55 ± 6.37 | 0.803 |
| Aldosterone (ng/dL) | |||
| N, Mean ± SD | 11.19 ± 10.48 | 39.57 ± 38.67 | <0.001 |
| A/PRA | |||
| N, Mean ± SD | 12.64 ± 18.04 | 100.13 ± 101.58 | <0.001 |
| A/PRC | |||
| N, Mean ± SD | 0.81 ± 1.29 | 8.46 ± 6.75 | <0.001 |
BMI: body mass index; SBP: systolic blood pressure, DBP: diastolic blood pressure; K+: concentration of serum potassium; HbA1c: glycated hemoglobin; A/PRA: aldosterone to plasma renin activity ratio; A/PRC: aldosterone to plasma renin concentration ratio.